Search
for
Sort by
Research 421–450 of 1000+
- New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
- Olive oil regenerates the hair lost during the alopecia complication caused through SARS Co-2 infection as well as with vaccination
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection
- Androgen sensitivity gateway to COVID‐19 disease severity
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- The role of androgens in COVID-19
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- COVID ‐19 induced telogen effluvium
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
- COVID-19 Infection: Impact on Hair
- Association between alopecia areata and COVID-19: A systematic review
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Comment on: The Gabrin sign
- Not just thinning: A case of alopecia universalis after mild COVID-19